Jennison Associates LLC C4 Therapeutics, Inc. Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$19.99 - $33.23 $539,749 - $897,243	-27,001 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$29.39 - $46.86 $13.5 Million - $21.5 Million	-458,312 Reduced 94.44%	27,001 $869,000
Q3 2021 Nov 09, 2021	SELL	$35.91 - $50.5 $102,774 - $144,531	-2,862 Reduced 0.59%	485,313 $21.7 Million
Q2 2021 Aug 12, 2021	SELL	$30.39 - $42.18 $90,349 - $125,401	-2,973 Reduced 0.61%	488,175 $18.5 Million
Q1 2021 May 11, 2021	BUY	$31.96 - $46.5 $10.2 Million - $14.8 Million	317,796 Added 183.32%	491,148 $18.2 Million
Q4 2020 Feb 05, 2021	BUY	$22.8 - $37.05 $3.95 Million - $6.42 Million	173,352 New	173,352 $5.74 Million

130

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $214M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.